Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Toyota Motor projects a drop in fiscal-year profit and announces a share buyback. The company gives a weak outlook after a scandal prompts output cuts. On the other hand, Takeda Pharmaceutical reports a significant decrease in full-year earnings as it focuses on rebuilding its drug pipeline due to the loss of patent protection for major sellers. Takeda also projects lower annual profit after a quarterly loss and plans to incur $900 million in one-time restructuring costs to improve margins. As part of its restructuring, Takeda has cut some clinical-phase pipeline programs to focus on its most promising candidates.
Takeda has made some cuts to its clinical-phase pipeline, hacking off midphase programs and early-stage prospects as part of a push to focus on its most promising candidates. https://t.co/lyLcdcahdM
Japan's Takeda Pharmaceutical announced a restructuring on Thursday after annual profit slid by more than half following the loss of patent protection of major sellers. https://t.co/EVMGpiIe9N https://t.co/EVMGpiIe9N
Takeda says it will incur $900 million in one-time restructuring costs in fiscal year 2024, as the Japanese drugmaker embarks on a multi-year program to improve margins https://t.co/BGxoko49wl
